Shazia Anwer Bukhari; Muhammad Masood Ahmed; Fozia Anjum; Haseeb Anwar; Syed Ali Raza Naqvi; Tauseef Zahra; Uzma Batool
(Karachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachi, 2018-07-17)
Prevalence of hepatitis C virus (HCV) has been seen in more than 15% of Pakistani population. For the
treatment of this infection, only two medicines, interferon, and ribavirin were approved in 1998. The concerned
physicians ...